Biotech
> Leone Patterson joined diaDexus as the company's chief financial officer. Release
> Chamaeleo Pharma appointed Han Van 't Klooster as the company's vice president of commercial operations. Release
> Incyte hired Dr. Steven Stein as its new chief medical officer. Release
> Dominique Laymand joined Ipsen as its vice president and chief ethics and compliance officer. Release
> Ramesh Tharuvai joined Macrocure as the company's vice president of operations. Release
> Sundia CEO Dr. Chen Chen retired to be succeeded by Dr. Jim Li. Release
> EyeGate Pharma named Dr. Michael Raizman its consulting chief medical officer. Release
> Dr. David Rimm joined Biocept as a scientific adviser. Release
> Fred Kurland retired from Xoma ($XOMA) to be succeeded by Thomas Burns as chief financial officer. Release
> Atara Biotherapeutics ($ATRA) appointed David Carmel as its head of immunotherapy. Release
> Tetraphase Pharmaceuticals ($TTPH) appoints Maria Stahl as senior vice president and general counsel. Release
> Inovio ($INO) adds Nancy Wysenski to its board of directors. Release
> Anavex appoints Corinne Lasmézas to its scientific advisory board. Release
> TWi Pharma appoints Tina Guilder as president and CEO. Guilder will continue to serve as president of its subsidiary, TWi Pharmaceuticals USA. Current president Calvin Cheng will become special adviser to Guilder, and Eva Ho will become TWi's CFO. Release
> AMRI ($AMRI) appoints Michael Pettersson as vice president of international sales. Release
> ThromboGenics appoints Dr. Joseph Markoff as scientific adviser. Release
> Revolution Medicines has named Dr. Carole Sable as chief medical officer and Luan Wilfong as vice president of human resources. Release
> Tim Coughlin joins Retrophin's ($RTRX) board of directors as an independent director effective March 31. Release
> InMed Pharma has appointed Dr. Ado Mohammed as chief medical officer. Release
> KemPharm names Tracy Woody as chief commercial officer. Release
> Adaptimmune names Rafael Amado as chief medical officer and Adrian Rawcliffe as chief financial officer, effective March 16. Release
> Laurus Synthesis appoints Charles Montgomery as vice president of chemistry and Raymond Forslund as senior director of project management. Release
> Laurence Reid succeeds Gregory Verdine as CEO of Warp Drive Bio. Verdine will continue to serve the company as chief scientific officer, president and chairman of the scientific advisory board. Release
> PhaseBio appoints Clay Thorp as executive chairman of the board, Jonathan Mow as chief executive officer and James Ballance as vice president of research and scientific affairs. Release (PDF)
> NGM Biopharma names Jeff Jonker president and David Woodhouse as chief financial officer. Release (PDF)
Pharma
> Former Novartis ($NVS) executive Tony Rosenberg joined the Radius ($RDUS) board of directors. Release
Biotech Research
> Jim Van Heusden will be the new CEO of Karolinska Development. Release
|